Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Moreira

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Cancer|September 27, 2024
Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) TrialRenning Zheng, James P Daniels, Daniel M Moreira, et al.
European Urology|June 6, 2015
Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive NephrectomyBoris Gershman, Daniel M Moreira, Stephen A Boorjian, et al.
European Urology|January 18, 2017
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical ResectionBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
Urology|November 17, 2019
Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative BiopsyLogan S Schwarzman, Rodrigo L Pagani, Samuel J Ohlander, et al.
The Journal of Urology|September 6, 2017
Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCEBrandee L Branche, Lauren E Howard, Daniel M Moreira, et al.
BJU International|September 4, 2019
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trialEmma H Allott, Ilona Csizmadi, Lauren E Howard, et al.
Cancer|October 16, 2013
Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, William J Aronson, Martha K Terris, et al.
The Journal of Urology|February 4, 2017
Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of CareBoris Gershman, Sarah K Meier, Molly M Jeffery, et al.
European Urology|November 15, 2017
Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based AnalysisBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
The Journal of Urology|September 25, 2016
Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based AnalysisBoris Gershman, R Houston Thompson, Daniel M Moreira, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Cancer|September 27, 2024
Does insulin resistance predict prostate cancer? Results from the Reduction by Dutasteride of Prostate Cancer (REDUCE) TrialRenning Zheng, James P Daniels, Daniel M Moreira, et al.
European Urology|June 6, 2015
Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive NephrectomyBoris Gershman, Daniel M Moreira, Stephen A Boorjian, et al.
European Urology|January 18, 2017
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical ResectionBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
Urology|November 17, 2019
Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative BiopsyLogan S Schwarzman, Rodrigo L Pagani, Samuel J Ohlander, et al.
The Journal of Urology|September 6, 2017
Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCEBrandee L Branche, Lauren E Howard, Daniel M Moreira, et al.
BJU International|September 4, 2019
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trialEmma H Allott, Ilona Csizmadi, Lauren E Howard, et al.
Cancer|October 16, 2013
Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, William J Aronson, Martha K Terris, et al.
The Journal of Urology|February 4, 2017
Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of CareBoris Gershman, Sarah K Meier, Molly M Jeffery, et al.
European Urology|November 15, 2017
Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based AnalysisBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
The Journal of Urology|September 25, 2016
Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based AnalysisBoris Gershman, R Houston Thompson, Daniel M Moreira, et al.
Pageof 15